Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Satoru Matsuda
Hirofumi Kawakubo
Akihiko Okamura
Keita Takahashi
Tasuku Toihata
Ryo Takemura
Shuhei Mayanagi
Hiroya Takeuchi
Masayuki Watanabe
Yuko Kitagawa
机构：
[1] Keio University School of Medicine,Department of Surgery
[2] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterological Surgery
[3] Keio University Hospital,Biostatistics Unit, Clinical and Translational Research Center
[4] Hamamatsu University School of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8438 / 8447
页数：9
相关论文
共 50 条
  • [31] Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery
    Ohsawa, Manato
    Hamai, Yoichi
    Emi, Manabu
    Takaoki, Furukawa
    Ibuki, Yuta
    Tomoaki, Kurokawa
    Yoshikawa, Toru
    Okada, Morihito
    [J]. ANTICANCER RESEARCH, 2020, 40 (02) : 1153 - 1160
  • [32] Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
    Kitasaki, Nao
    Hamai, Yoichi
    Emi, Manabu
    Kurokawa, Tomoaki
    Yoshikawa, Toru
    Hirohata, Ryosuke
    Ohsawa, Manato
    Okada, Morithito
    [J]. IN VIVO, 2022, 36 (06): : 2852 - 2860
  • [33] A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
    Wu, Lei-Lei
    Ma, Qi-Long
    Huang, Wei
    Liu, Xuan
    Qiu, Li-Hong
    Lin, Peng
    Long, Hao
    Zhang, Lan-Jun
    Ma, Guo-Wei
    [J]. BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [34] A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
    Lei-Lei Wu
    Qi-Long Ma
    Wei Huang
    Xuan Liu
    Li-Hong Qiu
    Peng Lin
    Hao Long
    Lan-Jun Zhang
    Guo-Wei Ma
    [J]. BMC Gastroenterology, 21
  • [35] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Mine, Shinji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2198 - 2199
  • [36] Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
    Han, Weiming
    Deng, Wei
    Wang, Qifeng
    Ni, Wenjie
    Li, Chen
    Zhou, Zongmei
    Liang, Jun
    Chen, Dongfu
    Feng, Qinfu
    Bi, Nan
    Zhang, Tao
    Wang, Xin
    Deng, Lei
    Wang, Wenqing
    Liu, Wenyang
    Wang, Jianyang
    Xue, Qi
    Mao, Yousheng
    Liu, Xiangyang
    Fang, Dekang
    Li, Jian
    Wang, Dali
    Zhao, Jun
    Xiao, Zefen
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Shinji Mine
    [J]. Annals of Surgical Oncology, 2024, 31 : 2198 - 2199
  • [38] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Mine, Shinji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2198 - 2199
  • [39] Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell carcinoma
    Wang, Honglei
    Jiang, Zeying
    Wang, Qihua
    Wu, Tong
    Guo, Fangzhou
    Xu, Zhengyuan
    Yang, Weixiong
    Yang, Shicong
    Feng, Shiting
    Wang, Xiaoyan
    Chen, Shuling
    Cheng, Chao
    Chen, Wenfang
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 186 : 196 - 210
  • [40] Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor after Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
    Satoru Matsuda
    Hirofumi Kawakubo
    Takayuki Tsuji
    Junya Aoyama
    Yuki Hirata
    Ryo Takemura
    Shuhei Mayanagi
    Tomoyuki Irino
    Kazumasa Fukuda
    Rieko Nakamura
    Hiroya Takeuchi
    Yuko Kitagawa
    [J]. Annals of Surgical Oncology, 2022, 29 : 2673 - 2680
12345